Free CME from PeerView


Cardiology CME

Credits: 1.25 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Critical Conversations on Venous Thromboembolism: A MasterClass Series on DVT and PE
Alexander (Ander) T. Cohen, MBBS, MSc, MD, FRACP, FESC, FRCP
December 16, 2022
Credits: 1.0 CME
University of Florida College of Medicine
Personalizing the Management of Hyperlipidemia: Addressing Unmet Needs Among High-Risk Patients With Atherosclerotic Cardiovascular Disease With Novel Lipid-Lowering Therapies
Peter H. Jones, MD, MNLA / R. Scott Wright, MD
November 07, 2022
Credits: 1.5 CME
Medical Learning Institute, Inc.
How I Think, How I Treat: Cardiology-Focused Perspectives on Using SGLT2 Inhibitors to Optimize Outcomes in Patients With Heart Failure
Javed Butler, MD, MPH, MBA
November 06, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Updating Our Cardio-Oncology Skills in the Cancer Immunotherapy Era: Team-Based Strategies for Risk Assessment, Diagnosis, and Management of Myocarditis and Other Cardiac Immune-Related Adverse Events
Javid Moslehi, MD
November 05, 2022
Credits: 1.0 CME
University of Cincinnati
Diagnosing and Treating Hyperlipidemia in Family Medicine: Exploring the Latest Clinical Evidence and the Role of Novel PCSK9-Targeting Therapies
R. Scott Wright, MD
October 28, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
Heart Failure Society of America
Pushing Back Against HCM: Can Cardiac Myosin Inhibitors Alter the Disease Progression and Management Trajectory for Patients With Hypertrophic Cardiomyopathy?
Milind Desai, MD, MBA
October 21, 2022
Credits: 0.5 CME
University of Florida College of Medicine
Envisioning the Future of Hyperlipidemia Management: How Can We Leverage PCSK9-Targeting Therapies to Prevent Primary and Secondary Cardiovascular Events?
Norman E. Lepor, MD, FACC, FAHA, FSCAI
September 29, 2022
Credits: 1.0 CME / MOC
PeerView Institute
Going Beneath the Surface of Hypertrophic Cardiomyopathy: Understanding the Pathophysiology and Deploying New Strategies for Timely Diagnosis and Targeted Treatment
Anjali Tiku Owens, MD
August 30, 2022
Credits: 0.75 CME / MOC
University of Florida College of Medicine
New Therapies, New Hope: Evolving Strategies for Improving Outcomes and Quality of Life in Patients With Hypertrophic Cardiomyopathy
Professor Perry Elliott, MBBS, MD, FRCP, FESC, FACC
May 12, 2022
Credits: 1.0 CME / CPE
PVI, PeerView Institute for Medical Education
Taking the Pulse of Undiagnosed Atrial Fibrillation: Pharmacists as a Lynchpin of Detection and Team-Based Care
Joe R. Anderson, PharmD, PhC
May 06, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
New Evidence on Cardiac Myosin Inhibition in Hypertrophic Cardiomyopathy: Analysis From Washington, DC
Milind Desai, MD, MBA
April 20, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Primary Care Call to Action for VTE Management: Sharpening Skills in Recognition, Treatment, and Secondary Prevention
Geoffrey Barnes, MD, MSc
March 31, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets With GLP-1 RAs
John B. Buse, MD, PhD
March 25, 2022
Credits: 1.5 CME
Medical Learning Institute, Inc.
Mastering the Use of Dual Antiplatelet Therapy for Preventing Recurrent Stroke: How Well Do Your Current Strategies Match With the Experts?
Gregory W. Albers, MD / S. Claiborne “Clay” Johnston, MD, PhD
February 11, 2022
Medical Learning Institute, Inc.
Advancing the Standard of Care for Patients with Hyperkalemia: Insights and Evidence for Clinical Pharmacy Practice
George L. Bakris, MD
December 07, 2021
PVI, PeerView Institute for Medical Education
Improving the Detection and Management of Cardiac Immune-Related Adverse Events in Patients With Cancer Is a Must: Are You Prepared?
Javid Moslehi, MD
November 15, 2021
PVI, PeerView Institute for Medical Education
Making New Strides in Hypertrophic Cardiomyopathy: The Latest Guidelines, Science, and Strategies for Early Diagnosis and Tailored Treatment
Neal K. Lakdawala, MD / Anjali Tiku Owens, MD
November 13, 2021
Medical Learning Institute, Inc.
Interprofessional Perspectives on Safety Management With Targeted Therapy for B-Cell Malignancies
Anthony R. Mato, MD, MSCE
October 04, 2021
Heart Failure Society of America
Easing the Burden of Hypertrophic Cardiomyopathy: Progress in Understanding and Addressing Its Pathophysiology
Daniel Jacoby, MD
October 01, 2021
Medical Learning Institute, Inc.
Breaking Therapeutic Barriers in RRMM: Team-Based Solutions for Integrating Novel Antibody Platforms and Improving Myeloma Care
Sagar Lonial, MD, FACP
October 01, 2021
Alok A. Khorana, MD, FACP, FASCO / Robert D. McBane, II, MD
Medical Learning Institute, Inc.
Reducing the Global Burden of Cancer-Associated VTE: Applying Guideline-Concordant, Evidence-Based Care and Shared Decision-Making Strategies to Improve Patient Outcomes
Alok A. Khorana, MD, FACP, FASCO / Robert D. McBane, II, MD
August 10, 2021
Medical Learning Institute, Inc.
The Contemporary Use of GLP-1 RAs to Individualize Therapy in T2DM: Candid Conversations on Glycemic and Nonglycemic Effects
James R. Gavin III, MD, PhD
July 27, 2021
Medical Learning Institute, Inc.
Determining Which Patients Will Benefit From GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM
Vanita R. Aroda, MD
July 16, 2021
Medical Learning Institute, Inc.
A New Treatment Era for Light Chain Amyloidosis: Interprofessional Lessons From a Center of Excellence
Suzanne Lentzsch, MD, PhD
July 09, 2021
Penn State College of Medicine
Management of Hyperlipidemia in the Family Medicine Setting: Diagnosis, Management, and the Role of Emerging Lipid-Lowering Therapies
James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA
June 22, 2021
Medical Learning Institute, Inc.
Advancing the Treatment of Pompe Disease: Clinical Updates in Newborn Screening and Enzyme Replacement
Loren D.M. Pena, MD, PhD
June 10, 2021
Medical Learning Institute, Inc.
Recognizing and Treating Hyperkalemia in Patients With Heart Failure and/or Chronic Kidney Disease: An Update for Hospitalists
George L. Bakris, MD
May 31, 2021
University of Florida College of Medicine
Lower Is Better: Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C Levels in Patients With Hyperlipidemia and ASCVD
Professor Kausik Ray
May 27, 2021
Medical Learning Institute, Inc.
Simulation – Striking a Balance: Weighing the Benefits and Risks of Treatment With Direct Oral Anticoagulants in Individuals With Nonvalvular Atrial Fibrillation or Venous Thromboembolism
Sean Pokorney, MD, MBA
April 21, 2021
Medical Learning Institute, Inc.
Applying Evidence to Practice: Updated Consensus Recommendations for the Diagnosis, Surveillance, and Management of Tuberous Sclerosis Complex
Elizabeth A. Thiele, MD, PhD
April 14, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView